Position in URGN
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$2,279,558
-$732,955 QoQ
Shares Held
126,783
-1.4% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,555,077,811 across 347 Biotechnology names. URGN ranks #172 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in URGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,279,558 | 126,783 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $3,012,513 | 128,630 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,163,656 | 108,454 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $3,632,102 | 265,117 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,176,629 | 196,802 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $771,826 | 72,472 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $844,409 | 66,489 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,108,922 | 66,086 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $795,945 | 53,063 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,074,960 | 71,664 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $607,164 | 43,338 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $326,842 | 31,579 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,206,882 | 130,615 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,068,622 | 120,476 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $998,998 | 120,072 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,012,341 | 123,607 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,117,640 | 128,317 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $392,401 | 41,262 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $614,652 | 36,543 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,368,725 | 89,635 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $649,111 | 33,322 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $616,030 | 34,186 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $249,978 | 12,959 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $356,929 | 13,665 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $227,815 | 12,770 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||